ImmunoScape vs Juno Therapeutics
ImmunoScape vs Juno Therapeutics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ImmunoScape is on 58/100 and Juno Therapeutics on 66/100.
Where each one leads
ImmunoScape
Leads on none of the measures we hold for both companies.
Juno Therapeutics
- our overall score: 66/100 against 58/100
- funding raised: $317M against $49.7M
At a glance
| Measure | ImmunoScape | Juno Therapeutics |
|---|---|---|
| What it is | Developing novel immunotherapies and diagnostics for cancer. | Biotechnology company focused on developing cancer immunotherapies. |
| Category | Biotechnology, Cancer, Immunotherapy, Diagnostics | Biotechnology, Pharmaceuticals, Cancer Immunotherapy, Cart |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2017 | 2013 |
| Headquarters | Singapore, Singapore | Seattle, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | ImmunoScape | Juno Therapeutics |
|---|---|---|
| Total funding | $49.7M | $317M |
| Latest round | Series B2 | Series B |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 4,364 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ImmunoScape | Juno Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 58/100 | 66/100 |
| Traction | 38/100 | 40/100 |
| Team | 70/100 | 90/100 |
| Community | Not published | 15/100 |
| Search visibility | 23/100 | 15/100 |
| Quality | 68/100 | 87/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | Not published |
| Domain ratingLink authority, 0-100 | 28/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ImmunoScape | Juno Therapeutics |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Not detected |
What users say
| Measure | ImmunoScape | Juno Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | 6 positive, 0 negative across 6 threads | Not published |
“Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments.”r/Quantisnow
ImmunoScape vs Juno Therapeutics: common questions
Which is better, ImmunoScape or Juno Therapeutics?
On our 0-100 score Juno Therapeutics rates higher (66/100 against 58/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do ImmunoScape and Juno Therapeutics compare on the numbers?
Juno Therapeutics leads on our overall score (66/100 against 58/100), funding raised ($317M against $49.7M).
What do real users say about ImmunoScape and Juno Therapeutics?
ImmunoScape: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/Quantisnow.
Read the full ImmunoScape review and pricing or the Juno Therapeutics review and pricing. You can also browse other ImmunoScape alternatives we track.